Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Fabrice Egros currently holds 32,000 shares of Syndax Pharmaceuticals Inc (SNDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Fabrice Egros has been a net seller of SNDX stock. They have purchased $0 and sold $1.0M worth of shares.
Fabrice Egros's most recent insider trade was on Feb 2, 2022, when they sold 16,000 shares at $0.00 per share.
Fabrice Egros serves as Executive at Syndax Pharmaceuticals Inc (SNDX). They have executed 16 insider transactions totaling $1.0M over their tenure at the company.
Fabrice Egros holds the position of Executive at Syndax Pharmaceuticals Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Fabrice Egros has shown a selling trading pattern, with $0 in total purchases and $1.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Fabrice Egros was on Nov 18, 2021, when they sold $252.4K worth of SNDX shares. This transaction involved 14,000 shares at $18.03 per share.
Fabrice Egros currently owns 32,000 shares of Syndax Pharmaceuticals Inc (SNDX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Fabrice Egros's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Fabrice Egros has 16 Form 4 filings on record as an insider at Syndax Pharmaceuticals Inc.
Set alerts for Fabrice Egros and 40,000+ other insiders.